Replies to post #70688 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Apparent Rapid Progressors are also Apparent pseudo progressors which represents the living people in first chart. Why would things be so much better in the info arm when from the PI trial:

from German label:

recurrent glioblastoma
13 patients with recurrent glioblastoma were treated with DCVax-L injections treated. The median survival was 11.8 months.

And by UCLA's own admission:

As might be expected, those patients with bulky, progressively growing tumors at the time of initial dendritic cell vaccination, regardless of whether they were newly diagnosed or recurrent, continued to have tumor progression despite active immunotherapy. For this subgroup of patients, the median overall survival was 11.7 months, which is not significantly different from those of historical and concurrent glioblastoma multiforme patients treated at our institution.